how are companies still selling compounded semaglutide

how are companies still selling compounded semaglutide Despite FDA ruling, GLP-1s giving Novo and Lilly headaches on the market Millions using weight-loss drug copycats

Name: how are companies still selling compounded semaglutide Despite FDA ruling, GLP-1s giving Novo and Lilly headaches on the market Millions using weight-loss drug copycats
Brand: shoeparkstore.com
SKU: 93290708557
Price: 23.66 USD
Availability: InStock
Rating: 4.7578000000000005 (14 reviews)

SKU: 93290708557

4.8

USD23.66 USD45.66

Pay in 4 interest-free payments of $5.92 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 2 - Sep 7

Description

Villaschi A, Ferrante G, Cannata F, Pini D, Pagnesi M, Corrada E, et al

"Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal"

In this case, the dynamics really do favour Lilly, and I expect the compounded tirzepatide market to shrink meaningfully over the next two years as pricing converges